TerminatedPhase 4

Lithotripsy for the Treatment of Gallstones

United States184 participantsStarted 2002-05

Plain-language summary

The purpose of this study is to determine the effectiveness and safety of using the Medstone lithotripter to treat single non-calcified gallstones from 4 to 20 mm in diameter.

Who can participate

Age range18 Years – 90 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

* History of biliary pain * Evidence of a single noncalcified, radiolucent gallstone between 4 and 20 mm (inclusive) diameter * HIDA scan demonstrating patency of cystic bile duct * No cardiac pacemaker * No allergy to radioopaque dye, iodine, bile acids * No spontaneous or iatrogenic bleeding disorder * No current or prior bile duct obstruction, cholangitis, pancreatitis, or cholecystitis * Not pregnant

Trial details

NCT IDNCT00042549

SponsorMedstone International

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Cholelithiasis trials